HIVE vs OXY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

HIVE

48.2
AI Score
VS
HIVE Wins

OXY

41.3
AI Score

Investment Advisor Scores

HIVE

48score
Recommendation
HOLD

OXY

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE OXY Winner
Forward P/E 62.8931 11.0254 OXY
PEG Ratio 0 0.8534 Tie
Revenue Growth 73.5% 53.4% HIVE
Earnings Growth -99.9% 964.9% OXY
Tradestie Score 48.2/100 41.3/100 HIVE
Profit Margin -98.5% 30.3% OXY
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HIVE 1M: -4.7% · 3M: -21.3% OXY 1M: +6.4% · 3M: +4.2%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

OXY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 67

RSI (14): 66.7 · Price: $61.30

Fundamentals Snapshot

Metric HIVE OXY
Market Cap
Forward P/E -5.9 16.0
Trailing P/E 17.7
Revenue (TTM)
Revenue Growth 0.7% 0.5%
Gross Margin 0.4% 0.7%
Operating Margin -0.6% 0.5%
EPS -1.54 3.47
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.